Rheumatic immune-related adverse events of checkpoint therapy for cancer - a podcast by BMJ Group

Cassandra Calabrese (Cleveland Clinic Foundation, Ohio, USA) speaks with Editor-in-Chief of RMD Open Bernard Combe about checkpoint inhibitors.
For more information, please visit the RMD Open website, where the related article to this podcast can also be found:

Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity: http://rmdopen.bmj.com/content/3/1/e000412.

Further episodes of RMD Open: Rheumatic and Musculoskeletal Diseases

Further podcasts by BMJ Group

Website of BMJ Group